Literature DB >> 3423426

Distribution of immunoreactive pancreatic phospholipase A2 (IPPL-2) in various human tissues.

Y Matsuda1, M Ogawa, T Shibata, K Nakaguchi, J Nishijima, C Wakasugi, T Mori.   

Abstract

Immunoreactive pancreatic phospholipase A2 exists in various human tissues other than the pancreas. Considerable amounts were detected in the lung, stomach, small intestine and kidney. Immunoreactive pancreatic phospholipase A2 in extra-pancreatic tissues was not accompanied by proportional phospholipase A2 activity in contrast to that in the pancreas.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3423426

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


  6 in total

1.  Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues.

Authors:  T J Nevalainen; T J Haapanen
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

2.  The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; Y Nakae
Journal:  Gastroenterol Jpn       Date:  1991-02

3.  Immunocytochemical studies on the localization of pancreatic-type phospholipase A2 in rat stomach and pancreas, with special reference to the stomach cells.

Authors:  H Tasumi; H Tojo; T Senda; T Ono; H Fujita; M Okamoto
Journal:  Histochemistry       Date:  1990

4.  Presence in human eosinophils of a lysophospholipase similar to that found in the pancreas.

Authors:  F W Holtsberg; L E Ozgur; D E Garsetti; J Myers; R W Egan; M A Clark
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

5.  Elevation of serum phospholipase A2 in patients at an intensive care unit.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; M Tanikawa; Y Nakae; S Kameya
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

6.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.